Brief: Bionano Genomics Q4 Revenue USD 10.7 Million Vs. IBES Estimate USD 10.6 Million
05/03/2024 21:01
Mar 05 (Reuters) - Bionano Genomics Q4 adjusted operating expenses USD 27.3 million. * Q4 operating expenses USD 27.4 million * Q4 gross margin 23% * outlook FY revenue USD 37-41 million
Recent news on Bionano Genomics
See all newsBionano Genomics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Bionano Genomics Q2 revenue rises on increased clinical adoption
Brief: Bionano Genomics Q2 Revenue USD 8.2 Million
Bionano Genomics, Inc. expected to post a loss of 68 cents a share - Earnings Preview
Bionano Genomics Q1 revenue up 4%, margin improves; to retire convertible debt